{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:55:09Z","timestamp":1777416909960,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperparathyroidism-Jaw Tumor (HPT-JT) is caused by inactivating germline mutations of CDC73. This hereditary disease can present with a range of symptoms. Jaw ossifying fibroma (OF) is one of the most important clinical presentations, affecting 30% of HPT-JT patients. However, OF is easily confused with other fibro-osseous lesions (FOLs) of the jaw. The correct diagnosis of HPT-JT is a real challenge and must be confirmed by genetic testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A female proband and her father suffered from multiple and recurrent FOLs in the jaw. Considering well demarcated margin and heterogeneous calcified substance lying in a variable density of fibrous stroma, we reached the diagnosis of jaw OF through radiologic and microscopic analyses. Additionally, the proband presented with chronic anemia resulting from menorrhagia, as well as renal mixed epithelial and stromal tumor (MEST). Two patients both presented with no evidence of Hyperparathyroidism (HPT). A germline start codon mutation (c.1A\u2009&gt;\u2009G) of CDC73 was identified in them. Copy number loss at the CDC73 gene locus was verified in the jaw tumor sample of the proband.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Regardless of whether HPT manifestations are present, patients with heritable jaw OF may be at risk for HPT-JT. Genetic testing should be adopted to confirm the diagnosis. Early recognition of HPT-JT helps to better develop tailored treatment plans and surveillance programs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01248-x","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T09:02:34Z","timestamp":1664010154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A two-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Dun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"issue":"4","key":"1248_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32(4):676\u201380. https:\/\/doi.org\/10.1038\/ng1048.","journal-title":"Nat Genet"},{"issue":"8","key":"1248_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck's Arch Surg. 2015;400(8):867\u201386. https:\/\/doi.org\/10.1007\/s00423-015-1342-7.","journal-title":"Langenbeck's Arch Surg"},{"key":"1248_CR3","doi-asserted-by":"publisher","first-page":"1761030","DOI":"10.1155\/2019\/1761030","volume":"2019","author":"F Torresan","year":"2019","unstructured":"Torresan F, Iacobone M. Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature. Int J Endocrinol. 2019;2019:1761030. https:\/\/doi.org\/10.1155\/2019\/1761030.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1248_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE, et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2005;257(1):18\u201326. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01421.x.","journal-title":"J Intern Med"},{"issue":"4","key":"1248_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M, Viel G, Porzionato A, Macchi V, et al. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer. 2008;15(4):1115\u201326. https:\/\/doi.org\/10.1677\/ERC-08-0066.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1248_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol. 2005;25(2):612\u201320. https:\/\/doi.org\/10.1128\/MCB.25.2.612-620.2005.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, et al. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol. 2005;25(12):5052\u201360. https:\/\/doi.org\/10.1128\/MCB.25.12.5052-5060.2005.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1248_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","volume":"125","author":"C Mosimann","year":"2006","unstructured":"Mosimann C, Hausmann G, Basler K. Parafibromin\/hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo. Cell. 2006;125(2):327\u201341. https:\/\/doi.org\/10.1016\/j.cell.2006.01.053.","journal-title":"Cell."},{"issue":"5\u20136","key":"1248_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.mod.2009.02.002","volume":"126","author":"C Mosimann","year":"2009","unstructured":"Mosimann C, Hausmann G, Basler K. The role of Parafibromin\/hyrax as a nuclear Gli\/ci-interacting protein in hedgehog target gene control. Mech Dev. 2009;126(5\u20136):394\u2013405. https:\/\/doi.org\/10.1016\/j.mod.2009.02.002.","journal-title":"Mech Dev"},{"issue":"7","key":"1248_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene. 2005;24(7):1272\u20136. https:\/\/doi.org\/10.1038\/sj.onc.1208274.","journal-title":"Oncogene"},{"issue":"1","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, et al. Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features. Am J Surg Pathol. 2019;43(1):35\u201346. https:\/\/doi.org\/10.1097\/PAS.0000000000001017.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1248_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, et al. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer. 2006;13(2):509\u201323. https:\/\/doi.org\/10.1677\/erc.1.01058.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"e97994","DOI":"10.1371\/journal.pone.0097994","volume":"9","author":"G Masi","year":"2014","unstructured":"Masi G, Iacobone M, Sinigaglia A, Mantelli B, Pennelli G, Castagliuolo I, et al. Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization. PLoS One. 2014;9(5):e97994. https:\/\/doi.org\/10.1371\/journal.pone.0097994.","journal-title":"PLoS One"},{"issue":"1","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2006.08.169","volume":"350","author":"C Zhang","year":"2006","unstructured":"Zhang C, Kong D, Tan MH, Pappas DL Jr, Wang PF, Chen J, et al. Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun. 2006;350(1):17\u201324. https:\/\/doi.org\/10.1016\/j.bbrc.2006.08.169.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1248_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat. 2010;31(3):295\u2013307. https:\/\/doi.org\/10.1002\/humu.21188.","journal-title":"Hum Mutat"},{"issue":"4","key":"1248_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/odi.12531","volume":"23","author":"GN Mainville","year":"2017","unstructured":"Mainville GN, Turgeon DP, Kauzman A. Diagnosis and management of benign fibro-osseous lesions of the jaws: a current review for the dental clinician. Oral Dis. 2017;23(4):440\u201350. https:\/\/doi.org\/10.1111\/odi.12531.","journal-title":"Oral Dis"},{"issue":"8","key":"1248_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2106\/JBJS.D.02942","volume":"87","author":"MR DiCaprio","year":"2005","unstructured":"DiCaprio MR, Enneking WF, Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848\u201364. https:\/\/doi.org\/10.2106\/JBJS.D.02942.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"1248_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000504802","volume":"92","author":"T Spencer","year":"2019","unstructured":"Spencer T, Pan KS, Collins MT, Boyce AM. The clinical Spectrum of McCune-Albright syndrome and its management. Horm Res Paediatr. 2019;92(6):347\u201356. https:\/\/doi.org\/10.1159\/000504802.","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"1248_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12105-018-0992-5","volume":"13","author":"BL Nelson","year":"2019","unstructured":"Nelson BL, Phillips BJ. Benign fibro-osseous lesions of the head and neck. Head Neck Pathol. 2019;13(3):466\u201375. https:\/\/doi.org\/10.1007\/s12105-018-0992-5.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"1248_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00125480-200105000-00002","volume":"8","author":"RB Brannon","year":"2001","unstructured":"Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol. 2001;8(3):126\u201343. https:\/\/doi.org\/10.1097\/00125480-200105000-00002.","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"1248_CR21","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1210\/jc.2017-01249","volume":"102","author":"K van der Tuin","year":"2017","unstructured":"van der Tuin K, Tops CMJ, Adank MA, Cobben JM, Hamdy NAT, Jongmans MC, et al. CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism. J Clin Endocrinol Metab. 2017;102(12):4534\u201340. https:\/\/doi.org\/10.1210\/jc.2017-01249.","journal-title":"J Clin Endocrinol Metab"},{"issue":"42","key":"1248_CR22","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.3760\/cma.j.issn.0376-2491.2013.42.010","volume":"93","author":"J Kong","year":"2013","unstructured":"Kong J, Wang O, Nie M, Shi J, Jiang Y, Li M, et al. CDC73 gene mutation and parafibromin expression status of parathyroid carcinoma in Chinese. Zhonghua Yi Xue Za Zhi. 2013;93(42):3364\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2013.42.010.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"9","key":"1248_CR23","doi-asserted-by":"publisher","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","volume":"7","author":"O Wang","year":"2012","unstructured":"Wang O, Wang C, Nie M, Cui Q, Guan H, Jiang Y, et al. Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. Plos One. 2012;7(9):e45567. https:\/\/doi.org\/10.1371\/journal.pone.0045567.","journal-title":"Plos One"},{"issue":"41","key":"1248_CR24","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","volume":"24","author":"MA Hahn","year":"2005","unstructured":"Hahn MA, Marsh DJ. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene. 2005;24(41):6241\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1208778.","journal-title":"Oncogene"},{"issue":"2","key":"1248_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","volume":"5","author":"L Lin","year":"2007","unstructured":"Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function. Mol Cancer Res. 2007;5(2):183\u201393. https:\/\/doi.org\/10.1158\/1541-7786.MCR-06-0129.","journal-title":"Mol Cancer Res"},{"key":"1248_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","volume":"124","author":"CD Vocke","year":"2019","unstructured":"Vocke CD, Ricketts CJ, Ball MW, Schmidt LS, Metwalli AR, Middelton LA, et al. CDC73 germline mutation in a family with mixed epithelial and stromal tumors. Urology. 2019;124:91\u20137. https:\/\/doi.org\/10.1016\/j.urology.2018.11.013.","journal-title":"Urology"},{"issue":"11","key":"1248_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/gcc.20911","volume":"50","author":"A Cascon","year":"2011","unstructured":"Cascon A, Huarte-Mendicoa CV, Javier Leandro-Garcia L, Leton R, Suela J, Santana A, et al. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosomes Cancer. 2011;50(11):922\u20139. https:\/\/doi.org\/10.1002\/gcc.20911.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"1248_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1507\/endocrj.EJ18-0387","volume":"66","author":"S Ciuffi","year":"2019","unstructured":"Ciuffi S, Cianferotti L, Nesi G, Luzi E, Marini F, Giusti F, et al. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity. Endocr J. 2019;66(4):319\u201327. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0387.","journal-title":"Endocr J"},{"issue":"9","key":"1248_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet. 2003;40(9):657\u201363. https:\/\/doi.org\/10.1136\/jmg.40.9.657.","journal-title":"J Med Genet"},{"issue":"10","key":"1248_CR30","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1359\/jbmr.060702","volume":"21","author":"TG Kelly","year":"2006","unstructured":"Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, et al. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res. 2006;21(10):1666\u201371. https:\/\/doi.org\/10.1359\/jbmr.060702.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jds.2019.12.007","volume":"15","author":"HM Ibrahem","year":"2020","unstructured":"Ibrahem HM. Ossifying fibroma of the jaw bones in hyperparathyroidism-jaw tumor syndrome: analysis of 24 cases retrieved from literatures. J Dent Sci. 2020;15(4):426\u201332. https:\/\/doi.org\/10.1016\/j.jds.2019.12.007.","journal-title":"J Dent Sci"},{"issue":"4","key":"1248_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12105-014-0590-0","volume":"8","author":"SK El-Mofty","year":"2014","unstructured":"El-Mofty SK. Fibro-osseous lesions of the craniofacial skeleton: an update. Head Neck Pathol. 2014;8(4):432\u201344. https:\/\/doi.org\/10.1007\/s12105-014-0590-0.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"1248_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4158\/EP12301.OR","volume":"19","author":"AF Turcu","year":"2013","unstructured":"Turcu AF, Clarke BL. Fibrous dysplasia of bone associated with primary hyperparathyroidism. Endocr Pract. 2013;19(2):226\u201330. https:\/\/doi.org\/10.4158\/EP12301.OR.","journal-title":"Endocr Pract"},{"issue":"2","key":"1248_CR34","first-page":"104","volume":"13","author":"PJ Slootweg","year":"1996","unstructured":"Slootweg PJ. Maxillofacial fibro-osseous lesions: classification and differential diagnosis. Semin Diagn Pathol. 1996;13(2):104\u201312.","journal-title":"Semin Diagn Pathol"},{"issue":"8","key":"1248_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/modpathol.2013.31","volume":"26","author":"RR Shi","year":"2013","unstructured":"Shi RR, Li XF, Zhang R, Chen Y, Li TJ. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw. Mod Pathol. 2013;26(8):1023\u201331. https:\/\/doi.org\/10.1038\/modpathol.2013.31.","journal-title":"Mod Pathol"},{"issue":"12","key":"1248_CR36","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1210\/jcem.81.12.8954016","volume":"81","author":"BT Teh","year":"1996","unstructured":"Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab. 1996;81(12):4204\u201311. https:\/\/doi.org\/10.1210\/jcem.81.12.8954016.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1248_CR37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/PAS.0000000000000733","volume":"40","author":"A Calio","year":"2016","unstructured":"Calio A, Eble JN, Grignon DJ, Delahunt B. Mixed epithelial and stromal tumor of the kidney: a clinicopathologic study of 53 cases. Am J Surg Pathol. 2016;40(11):1538\u201349. https:\/\/doi.org\/10.1097\/PAS.0000000000000733.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1248_CR38","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.juro.2009.01.004","volume":"181","author":"BP Portier","year":"2009","unstructured":"Portier BP, Hansel DE, Zhou M, Maclennan GT. Mixed epithelial and stromal tumor of the kidney. J Urol. 2009;181(4):1879\u201380. https:\/\/doi.org\/10.1016\/j.juro.2009.01.004.","journal-title":"J Urol"},{"issue":"4","key":"1248_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.14670\/HH-11-800","volume":"32","author":"WL Xie","year":"2017","unstructured":"Xie WL, Lian JY, Li B, Tian XY, Li Z. Mixed epithelial and stromal tumor of kidney with renal vein extension: an unusual case report and review of literature. Histol Histopathol. 2017;32(4):361\u20139. https:\/\/doi.org\/10.14670\/HH-11-800.","journal-title":"Histol Histopathol"},{"issue":"6","key":"1248_CR40","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.fertnstert.2012.08.017","volume":"98","author":"EF Wolff","year":"2012","unstructured":"Wolff EF, Hill MJ, Simonds WF, Segars JH. Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome. Fertil Steril. 2012;98(6):1616\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.08.017.","journal-title":"Fertil Steril"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01248-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T09:05:58Z","timestamp":1664010358000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01248-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01248-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"13 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent to publish the clinical data was obtained from the patient before the initiation of the report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}